{
  "id": "5357a514f1005d6b58000003",
  "type": "summary",
  "question": "How could U1 small nuclear RNA be used in therapeutics?",
  "ideal_answer": "Until now, two main types of therapeutic strategies have been developed using U1 small nuclear RNA (snRNA): 1) Production of a defective, but partially functional protein, with the help of exon skipping, through modulation of pre-mRNA splicing, and 2) Correction of pathogenic effects of splice donor site mutations with the use of U1 snRNA adapted to the defective variant.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22362925",
    "http://www.ncbi.nlm.nih.gov/pubmed/22968481",
    "http://www.ncbi.nlm.nih.gov/pubmed/20869034",
    "http://www.ncbi.nlm.nih.gov/pubmed/21326217",
    "http://www.ncbi.nlm.nih.gov/pubmed/22454066",
    "http://www.ncbi.nlm.nih.gov/pubmed/22454067",
    "http://www.ncbi.nlm.nih.gov/pubmed/21520335",
    "http://www.ncbi.nlm.nih.gov/pubmed/19219028"
  ],
  "snippets": [
    {
      "text": "Exon 45 skipping through U1-snRNA antisense molecules recovers the Dys-nNOS pathway and muscle differentiation in human DMD myoblasts",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22968481",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Here, we show the selection of U1 snRNA-antisense constructs able to confer effective rescue of dystrophin synthesis in a \u039444 Duchenne genetic background, through skipping of exon 45",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22968481",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "U1 small nuclear RNA have been used to carry antisense sequences",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22454067",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "we showed that bifunctional U7 snRNAs harboring silencer motifs induce complete skipping of exon 51, and thus restore dystrophin expression in DMD patients cells to near wild-type levels",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22454067",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These new constructs are very promising for the optimization of therapeutic exon skipping for DMD, but also offer powerful and versatile tools to modulate pre-mRNA splicing in a wide range of applications",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22454067",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "U1 snRNA as an effective vector for stable expression of antisense molecules and for the inhibition of the splicing reaction",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22454066",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We report the use of the U1 snRNA as a vector for the stable expression of antisense molecules against the splice junctions of specific dystrophin exons",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22454066",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Effective exon skipping has been obtained for different dystrophin exons by antisense sequences against 5' and 3' splice sites",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22454066",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "the U1-antisense molecules, delivered to mice via systemic injection of recombinant AAV viruses, displayed body wide transduction, long-term expression, dystrophin rescue as well as morphological and functional benefit",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22454066",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "U1 snRNA-mediated gene therapeutic correction of splice defects caused by an exceptionally mild BBS mutation",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21520335",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "For a gene therapeutic approach, we have adapted the sequence of U1 to increase its complementarity to the mutated SD. Lentiviral treatment of patient-derived fibroblasts with the adapted U1 partially corrected aberrant splicing of endogenously expressed BBS1 transcripts.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21520335",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our results show that the adaptation of U1 can correct pathogenic effects of splice donor site mutations and suggest a high potential for gene therapy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21520335",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Gene therapeutic approach using mutation-adapted U1 snRNA to correct a RPGR splice defect in patient-derived cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21326217",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "To correct the splice defect, we developed a gene therapeutic approach using mutation-adapted U1 small nuclear RNA (U1)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21326217",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Full complementarity of U1 corrects the splice defect partially and increases recognition of the mutant SDS. The therapeutic effect is U1-concentration dependent as we show for endogenously expressed RPGR transcripts in patient-derived cells",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21326217",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "U1-based gene therapeutic approaches constitute promising technologies to treat SDS mutations in inherited diseases including X-linked RP.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21326217",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Correct mRNA processing at a mutant TT splice donor in FANCC ameliorates the clinical phenotype in patients and is enhanced by delivery of suppressor U1 snRNAs.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20869034",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "use of lentiviral vectors as a delivery system to introduce expression cassettes for TT-adapted U1 snRNAs into primary FANCC patient fibroblasts allowed the correction of the DNA-damage-induced G2 cell-cycle arrest in these cells, thus representing an alternative transcript-targeting approach for genetic therapy of inherited splice-site mutations.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20869034",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Using F9 exon 5, CFTR exon 12 and SMN2 exon 7 models, we characterized natural mutations associated to exon skipping in Haemophilia B, cystic fibrosis and spinal muscular atrophy (SMA), respectively, and the therapeutic splicing rescue by using U1 small nuclear RNA (snRNA).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22362925",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "U1 Adaptors are bifunctional oligonucleotides with a 'target domain' complementary to a site in the target gene's terminal exon and a 'U1 domain' that binds to the U1 small nuclear RNA component of the U1 small nuclear ribonucleoprotein (U1 snRNP) splicing factor",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19219028",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012326",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000394",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0017069",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012322",
    "http://www.uniprot.org/uniprot/PRP24_YEAST",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000398",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000395",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012342",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0070054",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000379",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000373",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000372",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0008380",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D022821",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0043484",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000375",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000374",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016180",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0045292",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0030623",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0030620",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0030621",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0030626",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0030625",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0017070",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0071209",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000389",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0040031",
    "http://www.uniprot.org/uniprot/SF01_HUMAN",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0030619",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000365",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0051030",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0048024",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000945",
    "http://www.uniprot.org/uniprot/SUGP1_HUMAN"
  ]
}